Jpmorgan Chase & CO LEXEO THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
13,780
Previous 13,371 3.06%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
N/A
409 Added 3.06%
13,780 $0
Q4 2024

Feb 12, 2025
BUY
N/A
3,093 Added 30.09%
13,371 $0
Q3 2024

Dec 26, 2024
BUY
N/A
5,915 Added 135.57%
10,278 $0
Q3 2024

Nov 08, 2024
BUY
N/A
5,915 Added 135.57%
10,278 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-5,915 Reduced 57.55%
4,363 $0
Q2 2024

Aug 12, 2024
SELL
N/A
-1,590 Reduced 26.71%
4,363 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-4,325 Reduced 42.08%
5,953 $0
Q1 2024

May 10, 2024
BUY
N/A
5,841 Added 5215.18%
5,953 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-10,166 Reduced 98.91%
112 $0
Q4 2023

Feb 12, 2024
BUY
N/A
112 New
112 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email